|
1
|
Lim YS and Kim WR: The global impact of
hepatic fibrosis and end-stage liver disease. Clin Liver Dis.
12:733–746. vii2008. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Moreira RK: Hepatic stellate cells and
liver fibrosis. Arch Pathol Lab Med. 131:1728–1734. 2007.PubMed/NCBI
|
|
3
|
Brenner DA, Waterboer T, Choi SK,
Lindquist JN, Stefanovic B, Burchardt E, Yamauchi M, Gillan A and
Rippe RA: New aspects of hepatic fibrosis. J Hepatol. 32(Suppl 1):
S32–S38. 2000. View Article : Google Scholar
|
|
4
|
Okuno M, Akita K, Moriwaki H, Kawada N,
Ikeda K, Kaneda K, Suzuki Y and Kojima S: Prevention of rat hepatic
fibrosis by the protease inhibitor, camostat mesilate, via reduced
generation of active TGF-β. Gastroenterology. 120:1784–1800. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Ling H, Roux E, Hempel D, Tao J, Smith M,
Lonning S, Zuk A, Arbeeny C and Ledbetter S: Transforming growth
factor β neutralization ameliorates pre-existing hepatic fibrosis
and reduces cholangiocarcinoma in thioacetamide-treated rats. PLoS
One. 8:e544992013. View Article : Google Scholar
|
|
6
|
Yata Y, Gotwals P, Koteliansky V and
Rockey DC: Dose-dependent inhibition of hepatic fibrosis in mice by
a TGF-β soluble receptor: Implications for antifibrotic therapy.
Hepatology. 35:1022–1030. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Reddi AH: Role of morphogenetic proteins
in skeletal tissue engineering and regeneration. Nat Biotechnol.
16:247–252. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Huo L, Liu K, Pei J, Yang Y, Ye Y, Liu Y,
Sun J, Han H, Xu W and Gao Y: Fluoride promotes viability and
differentiation of osteoblast-like Saos-2 cells via BMP/Smads
signaling pathway. Biol Trace Elem Res. 155:142–149. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kretzschmar M and Massagué J: SMADs:
Mediators and regulators of TGF-β signaling. Curr Opin Genet Dev.
8:103–111. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wang SL, Yang CQ, Qi XL, Yuan M, Chang YZ,
Yang L and Gao HJ: Inhibitory effect of bone morphogenetic
protein-7 on hepatic fibrosis in rats. Int J Clin Exp Pathol.
6:897–903. 2013.PubMed/NCBI
|
|
11
|
Chen BL, Peng J, Li QF, Yang M, Wang Y and
Chen W: Exogenous bone morphogenetic protein-7 reduces hepatic
fibrosis in Schistosoma japonicum-infected mice via transforming
growth factor-β/Smad signaling. World J Gastroenterol.
19:1405–1415. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zeisberg M, Hanai J, Sugimoto H, Mammoto
T, Charytan D, Strutz F and Kalluri R: BMP-7 counteracts
TGF-beta1-induced epithelial-to-mesenchymal transition and reverses
chronic renal injury. Nat Med. 9:964–968. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Kinoshita K, Iimuro Y, Otogawa K, Saika S,
Inagaki Y, Nakajima Y, Kawada N, Fujimoto J, Friedman SL and Ikeda
K: Adenovirus-mediated expression of BMP-7 suppresses the
development of liver fibrosis in rats. Gut. 56:706–714. 2007.
View Article : Google Scholar
|
|
14
|
Yin SS, Wang BE, Wang TL, Jia JD and Qian
LX: The effect of Cpd 861 on chronic hepatitis B related fibrosis
and early cirrhosis: A randomized, double blind, placebo controlled
clinical trial. Zhonghua Gan Zang Bing Za Zhi. 12:467–470. 2004.In
Chinese. PubMed/NCBI
|
|
15
|
Wang L, Wang BE, Wang J, Xiao PG and Tan
XH: Herbal compound 861 regulates mRNA expression of collagen
synthesis- and degradation-related genes in human hepatic stellate
cells. World J Gastroenterol. 14:1790–1794. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wang L, Wang J, Wang BE, Xiao PG, Qiao YJ
and Tan XH: Effects of herbal compound 861 on human hepatic
stellate cell proliferation and activation. World J Gastroenterol.
10:2831–2835. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Aghaei I, Shabani M, Doustar N, Nazeri M
and Dehpour A: Peroxisome proliferator-activated receptor-γ
activation attenuates motor and cognition impairments induced by
bile duct ligation in a rat model of hepatic cirrhosis. Pharmacol
Biochem Behav. 120:133–139. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Javadi-Paydar M, Ghiassy B, Ebadian S,
Rahimi N, Norouzi A and Dehpour AR: Nitric oxide mediates the
beneficial effect of chronic naltrexone on cholestasis-induced
memory impairment in male rats. Behav Pharmacol. 24:195–206. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Uchinami H, Seki E, Brenner DA and
D'Armiento J: Loss of MMP 13 attenuates murine hepatic injury and
fibrosis during cholestasis. Hepatology. 44:420–429. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
21
|
Shen H, Huang G, Hadi M, Choy P, Zhang M,
Minuk GY, Chen Y and Gong Y: Transforming growth factor-beta1
downregulation of Smad1 gene expression in rat hepatic stellate
cells. Am J Physiol Gastrointest Liver Physiol. 285:G539–G546.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Yang T, Chen SL, Lu XJ, Shen CY, Liu Y and
Chen YP: Bone morphogenetic protein 7 suppresses the progression of
hepatic fibrosis and regulates the expression of gremlin and
transforming growth factor β1. Mol Med Rep. 6:246–252.
2012.PubMed/NCBI
|
|
23
|
Ding HG, Tang SZ, Wang BE, Jia JD and Zhao
CH: Effects of herbal compound 861 on hepatic stellate cell
expressing endo-thelin-1 protein and mRNA. Chin J Hepatol.
11:3082003.In Chinese.
|
|
24
|
Yin C, Ma H, Wang A, Ma X, Jia J and Wang
B: Effect of compound 861 on tissue inhibitor of metalloproteinase
1 gene expression of HSC-T6 cells. Chin J Hepatol. 10:197–199.
2002.In Chinese.
|
|
25
|
You H, Wang B and Wang T: Proliferation
and apoptosis of hepatic stellate cells and effects of compound 861
on liver fibrosis. Chin J Hepatol. 8:78–80. 2000.In Chinese.
|
|
26
|
Cheifetz S, Li IW, McCulloch CA, Sampath K
and Sodek J: Influence of osteogenic protein-1 (OP-1;BMP-7) and
transforming growth factor-beta 1 on bone formation in vitro.
Connect Tissue Res. 35:71–78. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Wang LP, Dong JZ, Xiong LJ, Shi KQ, Zou
ZL, Zhang SN, Cao ST, Lin Z and Chen YP: BMP-7 attenuates liver
fibrosis via regulation of epidermal growth factor receptor. Int J
Clin Exp Pathol. 7:3537–3547. 2014.PubMed/NCBI
|
|
28
|
Heldin CH, Miyazono K and ten Dijke P:
TGF-beta signalling from cell membrane to nucleus through SMAD
proteins. Nature. 390:465–471. 1997. View
Article : Google Scholar : PubMed/NCBI
|
|
29
|
Wrana JL: Regulation of Smad activity.
Cell. 100:189–192. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Wang S and Hirschberg R: Bone
morphogenetic protein-7 signals opposing transforming growth factor
beta in mesangial cells. J Biol Chem. 279:23200–23206. 2004.
View Article : Google Scholar : PubMed/NCBI
|
